Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Aclarion, Inc. (ACON) AI Forecast

Our AI analyzed Aclarion, Inc.. Create a free account to see the 90-day price prediction.

Free account • 30-day free trial

$ACON Neutral Signal Full forecast available

Aclarion, Inc. (ACON) Stock Forecast 2025


Aclarion, Inc. (ACON) AI Stock Price Forecast & Investment Analysis

Aclarion, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Aclarion, Inc. (ACON) - Comprehensive Stock Analysis & Investment Research

Deep dive into Aclarion, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 10, 2026, 11:00 a.m. (UTC)

Aclarion, Inc. Investment Summary

When evaluating whether Aclarion, Inc. (ACON) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Aclarion, Inc. (ACON) operates within the Industrial Applications and Services sector, specifically in the Services-Medical Laboratories industry. . With a market capitalization of $3 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Aclarion, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Aclarion, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Aclarion, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Aclarion, Inc.

Sign Up Free
Corporate Identity

Aclarion, Inc. (Stock Symbol: ACON) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Services-Medical Laboratories industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Aclarion, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Aclarion, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Aclarion, Inc....

Unlock Full Company Profile

Get complete details about Aclarion, Inc.

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Aclarion, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Aclarion, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Aclarion, Inc....

Unlock Financial Analysis

Get complete financial metrics for Aclarion, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Aclarion, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Aclarion, Inc. strategically competes in the highly dynamic Services-Medical Laboratories marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Aclarion, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-3 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Margin & Pricing Power Analysis

The company maintains a -85.4% gross margin characteristic of commodity-like businesses or high-volume, low-margin operators. Thin gross margins require exceptional operational efficiency and volume to generate meaningful profits. Companies at this margin level are particularly sensitive to cost increases or pricing pressures.

Operating margin of -8565.3% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Asset Utilization Efficiency

Asset turnover ratio of 0.03x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.

Financial Strength & Leverage

Current ratio of 0.06 reflects potential liquidity concerns with current liabilities exceeding current assets. While some businesses operate successfully with negative working capital, this warrants understanding of the specific circumstances.

Aclarion, Inc. (ACON) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Aclarion, Inc. stock analysis.

Deep dive into Aclarion, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Aclarion, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Aclarion, Inc.: With a P/E ratio of -0.03, the market sees the stock as potentially undervalued.

P/E Ratio -0.03x
P/B Ratio 0.28x
Market Cap $3M
EPS $-9.08
Book Value/Share $11.85
Revenue/Share $0.05
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Aclarion, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Aclarion, Inc.:

ROA -356.7%
Gross Margin -85.4%
Operating Margin -8565.3%
Net Margin -10371.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Aclarion, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Aclarion, Inc.: A current ratio of 0.06 suggests potential liquidity concerns.

Current Ratio 0.06x
Quick Ratio 0.01x
Interest Coverage -8.2x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Aclarion, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Aclarion, Inc.: Free cash flow of $-3M indicates cash challenges that need attention.

Operating Cash Flow -$2M
Free Cash Flow -$3M
CapEx/Sales 454.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Aclarion, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Aclarion, Inc.: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Receivables Turnover 4.6x
Fixed Assets Turnover 5.3x
Days Sales Outstanding 79 days
Payables Period 7301 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Aclarion, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Aclarion, Inc.:

Income Statement
Operating Income -$3M
Net Income -$3M
R&D Expense $820K
Cost of Goods Sold -$700K
Balance Sheet Highlights (% Of Assets)
Total Current Assets 31%
Cash & Short-term Investments 3%
Total Liabilities 483%
Short-term Debt 111%
Accounts Receivable 1%
Dividend & Shareholder Information
Shares Outstanding 1M
Growth Metrics (YoY)
EPS Growth -5044.4%

Latest Aclarion, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Aclarion, Inc. (ACON) stock price and investment outlook.

More news available

Sign up free to read all 11 news articles and stay updated on market developments.

Sign Up Free to Read More

Aclarion, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Aclarion, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aclarion, Inc. ACON ██% $3M 0.0x 0.3x
Advanced Biomed Inc. ADVB ██% $7M 1.0x 0.7x
American Shared Hospital Services AMS ██% $14M 5.2x 0.6x
Biodesix Inc BDSX ██% $160M -3.0x 140.7x
Bionexus Gene Lab Corp BGLC ██% $5M x 0.8x
Burning Rock Biotech Ltd BNR ██% $0.00M x 0.0x
Caris Life Sciences, Inc. CAI ██% $5.37B 50.5x 9.3x
Caredx, Inc. CDNA ██% $903M 16.5x 3.0x
Celcuity Inc. CELC ██% $4.91B -4.5x 42.0x
Castle Biosciences Inc CSTL ██% $802M -2110.5x 1.7x
Quest Diagnostics Inc DGX ██% $23.52B 23.7x 3.3x
Exact Sciences Corp EXAS ██% $19.75B -343.6x 8.2x
First Choice Healthcare Solutions, Inc. FCHS ██% $130K x 0.0x
Fulgent Genetics, Inc. FLGT ██% $455M 516.8x 0.4x
Fortrea Holdings Inc. FTRE ██% $915M -6.8x 1.6x
Guardant Health, Inc. GH ██% $11.91B -8.9x 174.5x
Grail, Inc. GRAL ██% $2.01B x 0.9x
Labcorp Holdings Inc. LH ██% $22.17B 25.3x 2.6x
Ludwig Enterprises, Inc. LUDG ██% $6M x x
Mdxhealth Sa MDXH ██% $162M x x
Natera, Inc. NTRA ██% $27.68B -74.2x 16.2x
Capforce Inc. OPGN ██% $242M x 23.8x
Psychemedics Corp PMDI ██% $9M x 1.8x
Personalis, Inc. PSNL ██% $696M -2.3x 2.7x
Radnet, Inc. RDNT ██% $4.49B 462.8x 4.1x
Renalytix Plc RENXF ██% $13M x x
Renalytix Plc RNLXY ██% $511M x 73.4x
Sera Prognostics, Inc. SERA ██% $88M -9.0x 1.1x
Veracyte, Inc. VCYT ██% $2.69B 40.5x 2.1x
Exagen Inc. XGN ██% $74M -5.4x 4.1x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Aclarion, Inc. Stock Forecast

How accurate are Aclarion, Inc. stock predictions?

Our AI model shows a 39% Spearman correlation coefficient for ACON predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Aclarion, Inc. stock price forecasts?

Our analysis considers Aclarion, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Aclarion, Inc. a good investment in 2025?

Based on our AI analysis, Aclarion, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Aclarion, Inc. forecasts updated?

Aclarion, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...